Skip to content

Phase I/Ib clinical trial of PM54 in Advance Solid Tumors patients

Status
Recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-508644-22-00
Enrollment
85
Registered
2023-11-14
Start date
2023-02-28
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advance Solid Tumors

Interventions

None listed

Sponsors

Pharma Mar S.A.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

Belgium, France, Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026